DM21 is a next-generation linker-payload that combines a maytansinoid microtubule-disrupting payload with a stable tripeptide linker. DM21 is conjugated with a humanized antibody against ADAM9 to obtain IMGC936[1].
Molecular Weight:
1215.84
Purity:
99.34
CAS Number:
[2243689-80-5]
Formula:
C58H83ClN8O16S
Target:
Drug-Linker Conjugates for ADC,Microtubule/Tubulin
Application Notes:
MCE Product type: ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted
